Metraipolis › archive › dc_cc2e655944d4

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib — Europe PMC PMID:41396990

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41396990
DOI
10.1371/journal.pone.0338188
License (as archived)
solo-consultazione
Archived
2026-11-07T15:52:07.119Z
SHA-256 of the archived text
01555510bb2c1b7cb766cde8e39ccb4d89028f2ee63f270c9157fd3002d99151
Stable URL of this page
https://metraipolis.com/documento/dc_cc2e655944d4

How to cite

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib — Europe PMC PMID:41396990 — Europe PMC (en), https://europepmc.org/article/MED/41396990 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc2e655944d4 (Metraipolis archive dc_cc2e655944d4, sha256 01555510bb2c1b7cb766cde8e39ccb4d89028f2ee63f270c9157fd3002d99151)
BibTeX
@misc{dccc2e655944d4,
  title = {A disproportionality analysis of FDA adverse event reporting system (FAERS) events for filgotinib — Europe PMC PMID:41396990},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41396990},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc2e655944d4; sha256 01555510bb2c1b7cb766cde8e39ccb4d89028f2ee63f270c9157fd3002d99151},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41396990. Agents can read the archived copy with the MCP tool read_document.